Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Allison Dillon"'
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8480-8490 (2020)
ABSTRACT Background Real‐world practice patterns, treatment sequencing, and outcomes in patients with metastatic pancreatic cancer remain unclear. Previous research indicates that the likelihood of patients with metastatic pancreatic cancer receivi
Externí odkaz:
https://doaj.org/article/9a32188badb443708867cdcac3ea311a
Autor:
Ana F Fonseca, Hannah Byrne, Andres Laguna, Taha Itani, Rachel Studer, Jihaeng Heo, Allison Dillon, Philippe Ferber, Madlaina Costa-Scharplatz
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:519-529
Publikováno v:
Journal of Clinical Oncology. 41:53-53
53 Background: Current treatment options for patients with metastatic colorectal cancer (mCRC) have limited efficacy and are associated with substantial toxicity, especially for patients with mCRC refractory to standard therapies. Targeted agents may
Autor:
Sumit Mohan, Frank A. Corvino, Daniel W. Kim, Weiying Wang, Allison Dillon, Demetra Tsapepas, S. Ali Husain, Kristen L. King, Tracy J. Mayne
Publikováno v:
Clin Transplant
Increased utilization of suboptimal organs in response to organ shortage has resulted in increased incidence of delayed graft function (DGF) after transplantation. Although presumed increased costs associated with DGF are a deterrent to the utilizati
Autor:
Teresa Kauf, Steffen Haldrup, Christian Ringemann, Allison Dillon, Inderjit Singh, Weiying Wang, John T. Odegard
Publikováno v:
Diabetes. 69
Objectives: While a large proportion of chronic kidney disease (CKD) cost in the U.S. is borne by Medicare, most CKD patients have commercial coverage, either as primary insurance or as a Medicare supplement. This study examines the economic impact o
Autor:
Allison Dillon, Inderjit Singh, Teresa Kauf, John T. Odegard, Weiying Wang, Steffen Haldrup, Christian Ringemann
Publikováno v:
Diabetes. 69
Objectives: Early diagnosis and treatment of chronic kidney disease (CKD) may delay disease progression and reduce the burden of disease. This study examined the epidemiology and treatment of CKD among commercially-insured patients in the U.S. Method
Publikováno v:
Journal of Clinical Oncology. 38:667-667
667 Background: Published data suggests prior exposure to irinotecan infers a lower likelihood of benefit to liposomal irinotecan. This analysis seeks to expand this hypothesis by evaluating U.S. patterns of care to understand how prior irinotecan th